COVID-19 mortality: are comorbidities, socio-economic status and ethnicity more important than cancer?

Seknazi, Lauren; Jamelot, Mathieu; Canouï-Poitrine, Florence; Gligorov, Joseph; Benderra, Marc-Antoine

Seknazi, Lauren; Jamelot, Mathieu; Canouï-Poitrine, Florence; Gligorov, Joseph; Benderra, Marc-Antoine.

Seknazi L; Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.
Jamelot M; Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.
Canouï-Poitrine F; Université Paris-Est Créteil, INSERM, IMRB, Créteil, France.
Gligorov J; AP-HP, Henri-Mondor Hospital, Public Health Department & Clinical Research Unit (URC Mondor), Créteil, France.
Benderra MA; Department of Medical Oncology, Institut Universitaire de Cancérologie, Sorbonne University, AP-HP, Tenon Hospital, Paris, France.

Ann Transl Med ; 10(24): 1302, 2022 Dec.

Article in English | MEDLINE | ID: covidwho-2204831

Keywords

Coronavirus disease 2019 (COVID-19); comorbidities; ethnicity

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Language: English Journal: Ann Transl Med Year: 2022 Document Type: Article Affiliation country: Atm-22-5592

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google